DKL:NYSEDelek Logistics Partners, L.P. Analysis
Data as of 2026-06-13 - not real-time
$53.02
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Delek Logistics Partners (DKL) is trading at $53.02, comfortably above its 20‑day SMA (51.66) and 50‑day SMA (51.03), with the 200‑day SMA (48.43) providing a clear long‑term upward bias. The RSI of 56.7 and a bullish MACD histogram (+0.22) reinforce a momentum‑friendly environment, while volume is on the rise, suggesting growing trader interest. Valuation metrics look attractive: the forward P/E of 9.6 is well below the industry average of 21.5, and the DCF‑derived fair value of $99.3 implies a substantial upside versus the current price. However, the dividend yield of 8.47% comes with a payout ratio of 141%, flagging sustainability concerns. The balance sheet shows $2.33 B of debt versus negligible cash, a debt‑to‑equity of 0 (due to negative equity) and negative free cash flow of $‑65.3 M, underscoring leverage risk. Recent news reveals a $800 M senior note issuance at 6.875% and a tender offer for 7.125% notes due 2028, which could further strain cash resources.
The stock’s beta of 0.24 and 30‑day volatility of ~30% indicate modest market sensitivity but heightened price swings. Operating margins (13.5%) and ROE (4.4%) are modest, and the negative book value per share (‑$0.38) adds a valuation caveat. Given the bullish technical backdrop, undervalued relative‑price multiples, but weak cash generation and aggressive dividend policy, DKL sits at a crossroads where short‑term upside is plausible but long‑term risk is elevated.
The stock’s beta of 0.24 and 30‑day volatility of ~30% indicate modest market sensitivity but heightened price swings. Operating margins (13.5%) and ROE (4.4%) are modest, and the negative book value per share (‑$0.38) adds a valuation caveat. Given the bullish technical backdrop, undervalued relative‑price multiples, but weak cash generation and aggressive dividend policy, DKL sits at a crossroads where short‑term upside is plausible but long‑term risk is elevated.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, bullish MACD)
- Valuation upside relative to DCF and forward P/E
- Increasing volume supporting momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High dividend yield offset by unsustainable payout ratio
- New senior note issuance increasing leverage
- Stable but modest operating performance
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Negative free cash flow and weak cash position
- Elevated debt levels and upcoming note maturities
- Dividend sustainability concerns and negative book value
Key Metrics & Analysis
Financial Health
Revenue Growth19.00%
Profit Margin16.00%
P/E Ratio16.7
ROE439.37%
ROA3.83%
P/B Ratio-140.6
Op. Cash Flow$375.9M
Free Cash Flow$-65278876
Industry P/E21.5
Technical Analysis
TrendBullish
RSI56.7
Support$49.13
Resistance$54.75
MA 20$51.66
MA 50$51.03
MA 200$48.43
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$99.32
Target Price$51.40
Upside/Downside-3.06%
GradeUndervalued
TypeBlend
Dividend Yield8.47%
Risk Assessment
Beta0.24
Volatility29.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.